<DOC>
	<DOC>NCT00309751</DOC>
	<brief_summary>The purpose of this study is to compare the efficacy and safety of pitavastatin with that of atorvastatin in patients with type II diabetes mellitus (type II DM) and combined dyslipidemia.</brief_summary>
	<brief_title>Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Males and females (ages 1875 years) Type II DM treated with oral antidiabetic medication (sulfonylurea, metformin, glitazones, or combination therapy) Must have been following a restrictive diet Diagnosis of combined dyslipidemia Homozygous familial hypercholesterolemia Conditions which may cause secondary dyslipidemia Uncontrolled diabetes mellitus Abnormal pancreatic, liver, or renal function Abnormal serum creatine kinase (CK) above the prespecified level Significant heart disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Kowa</keyword>
	<keyword>Type II Diabetes Mellitus</keyword>
	<keyword>Combined Dyslipidemia</keyword>
	<keyword>pitavastatin</keyword>
	<keyword>NK-104</keyword>
	<keyword>Atorvastatin</keyword>
</DOC>